Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Transplantation Market Share, Size, Growth, Analysis, Forecast: By Category of Product: Transplant Preservative Solutions, Transplant Diagnostics, Tissue Products, Immunosuppressive Drugs, Others; By Type of Transplant: Solid Organ Transplant, Others; By Application; By End-User; Regional Analysis; Supplier Landscape; 2023-2031

Global Transplantation Market Outlook

The global transplantation market size reached a value of USD 13.8 billion in 2022. The market is likely to grow at a rate of 9.4% in the forecast period of 2023-2031 to reach a market value of USD 31.5 billion by 2031. The increasing research and developmental activities, along with technological advancements are supporting the market growth.

 

Transplantation: Overview, Types, Uses, and Segmentation

Transplantation is one of the most advanced and great advances in modern medicine. Transplantation is a procedure of removing organ, tissue, or cells from one subject and surgically placing it in another subject whose organ has failed. The former is called the donor, while the latter is referred to as a recipient. Transplantation is generally considered the last therapeutic intervention in cases of organ failure or damage due to any disease or injury.

 

The organs that can be donated include the heart, kidneys, pancreas, uterus, liver, lungs, and intestine. The tissues being transplanted from the healthy donor to the recipient are the bones, heart valves, skin patches, tendons, cornea, and nerves. Out of the tissues, cornea and musculoskeletal grafts are majorly transplanted, while kidneys are the most transplanted organs in the human body.

 

There are several types of transplants, including autograft, allograft, domino transplants, xenograft, and ABO-incompatible transplants. The organs or tissues can be donated from either a living or deceased donor. There has been the formulation of several laws and regulations in both developed and developing countries for enhancing the safety and availability of organ or tissue transplants to their citizens.

 

The transplantation market can be categorised into the following segments:

Market Breakup by Product

  • Transplant Preservative Solutions
  • Transplant Diagnostics
  • Tissue Products
  • Immunosuppressive Drugs
  • Others

 

Market Breakup by Type of Transplant

  • Solid Organ Transplant
    • Kidney
    • Heart
    • Lungs
    • Liver
    • Intestine
    • Others
  • Stem Cell Transplant
    • Autologous Transplants
    • Allogenic Transplants
  • Tissue Transplant
    • Autografts
    • Allografts
  • Others

 

Transplantation Market Breakup by Application

  • Clinical Therapeutics
  • Translational Research
  • Diagnostic Purposes
  • Others

 

Market Breakup by End User

  • Hospitals
  • Transplantation Centres
  • Others

 

Market Breakup by Region

  • North America
    • United States of America
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

Market Scenario

The growth of the transplantation market is driven by the rising cases of organ failure, which can be attributed to the growing incidence of acute and chronic diseases, including poisoning, trauma, leukaemia, and sepsis. This has led to increased demand for tissue and organ transplants and thus will facilitate market growth and development.

 

The emergence of unhealthy eating habits, increased consumption of alcohol, drug abuse and lack of physical exercise are also increasing the chances of organ failure. This is anticipated to accelerate the demand for organ or tissue transplants and will directly influence the growth of the transplantation market during the forecast period.

 

Tissue Products is Anticipated to Hold a Maximum Share

Tissue products are expected to hold a significant share in the market owing to the increasing number of transplantation procedures incorporating the application of tissue products, such as orthopaedic soft tissues, heart valves, and bone marrow. This is expected to attribute to the major share of this segment. The growing number of product launches and approvals and the rising number of mergers and acquisitions are also projected to fuel the market development.

 

North America Accounts for the Largest Share

North America is anticipated to dominate the transplantation market due to the well-developed healthcare facilities and the strategic presence of major pharmaceutical companies, like Arthrex, Zimmer Biomet, Stryker, Novartis, and Medtronic in the region. Further, the increasing initiatives by the government and other non-governmental organisations to aware people of organ donations are also expected to accelerate the market in the forthcoming years.

 

Therapeutic Landscape

Transplantation is a wide branch of modern medicine and is used for the treatment of several therapeutic indications. Tremendous efforts of scientists, researchers, and healthcare professionals have led to innovative transplantation methods that have helped to improve healthcare and the global economy.

 

One of the emerging therapies incorporating transplantation is cell transplantation or cell therapy. The therapeutic interventions include hematopoietic stem cell transplantation, neural stem cell therapy, and mesenchymal stem cell therapy. These therapies are utilized in the cases of myeloid malignancies, osteogenesis imperfecta, Hurler’s syndrome, and other haematological indications.

 

The transplantation of the entire bladder or the bladder tissue from a healthy donor to the recipient has also provided therapeutic effects in the management of renal disorders. The bladders are biosynthesized which can be then transplanted into the patient’s body. Kidney and liver transplants are being utilized in case of renal dysfunction and hepatic failure.

 

A heart transplant is used in patients suffering from congestive heart failure, for restoring the normal functioning of the heart. Other organ transplants including lung transplants are also used in the treatment of pulmonary disorders, wherein, one or both lungs have stopped functioning and the patient is expected to survive for less than two years.

 

Stem cell transplant is another transplantation technique which is applied for the management of the disease damaging the bone marrow cells. This type of transplant gives rise to novel blood cells, thus replacing the damaged cells in the body.

 

Clinical Trials Landscape

With extensive research and innovations, clinical researchers are working on discovering novel organ/tissue transplantations that would be useful in the treatment of novel therapeutic indications. The undergoing clinical trials are expected to utilize novel technologies and methods, that are more efficient therapeutically. 

 

In the United States, LyGenesis, a key market player is performing clinical trials for the novel technique, involves the development of ectopic livers. In this intervention, the cells are injected from the donor liver which is expected to form multiple mini livers thus, expected to keep the patient healthy. If successfully passed, this can be used for the management of patients suffering from end-stage liver disease.

 

A novel method of islet transplantation is under stage III clinical trials for testing the degree and effect of insulin independence in patients suffering from diabetes. In this method, the normal islet cells from the healthy donor are injected into the patient, which aids in the production of insulin and thus controls diabetes.

 

Paragonix technologies, a major market leader, has launched a novel organ tracking technology to make the entire in-transit of donor organs transparent. This will be used to capture the exact location of the device and thus, will help in early transportation and will increase the chances of saving the patient life.

 

The positive results of these trials, the invention of novel methods, better advancements and increased understanding and awareness will also propel the market expansion in the near future. 

 

Competitive Landscape:

The report gives an in-depth analysis of the key players involved in the market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The transplantation market companies included in the market are as follows:

 

  • AbbVie Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • 21st Century Medicine
  • BioLife Solutions
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2016-2022
Forecast Period 2023-2031
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Category of Product
  • Type of Transplant
  • Application
  • End-User
  • Region
Breakup by Category of Product
  • Transplant Preservative Solutions
  • Transplant Diagnostics
  • Tissue Products
  • Immunosuppressive Drugs
  • Others
Breakup by Type of Transplant
  • Solid Organ Transplant
  • Stem Cell Transplant
  • Tissue Transplant
  • Others
Breakup by Application
  • Clinical Therapeutics
  • Translational Research
  • Diagnostic Purposes
  • Others
Breakup by End-User
  • Hospitals
  • Transplantation Centres
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AbbVie Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • 21st Century Medicine
  • BioLife Solutions
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
        1.1.1     Research Objectives
        1.1.2     Key Findings of the Report
    1.2    Limitations of the Study and Scope for Future Research
2    Research Methodology
3    Executive Summary
4    Global Transplantation Overview

    4.1    Guidelines and Stages
    4.2    Pathophysiology
    4.3    Screening and Diagnosis
    4.4    Treatment Pathway 
5    Patient Profile
    5.1    Patient Profile Overview
    5.2    Patient Psychology and Emotional Impact Factors
    5.3    Risk Assessment and Treatment Success Rate
6    Global Transplantation Market
    6.1    Global Transplantation Market Overview
    6.2    Global Transplantation Market Analysis 
        6.2.1    Market Overview
            6.2.1.1    Global Transplantation Market Historical Value (2016-2022) 
            6.2.1.2    Global Transplantation Market Forecast Value (2023-2031)
        6.2.2    Global Transplantation Market by Category of Product
            6.2.2.1    Market Overview
                6.2.2.1.1    Transplant Preservative Solutions
                6.2.2.1.2    Transplant Diagnostics
                6.2.2.1.3    Tissue Products
                6.2.2.1.4    Immunosuppressive Drugs
                6.2.2.1.5    Others
        6.2.3    Global Transplantation Market by Type of Transplant 
            6.2.3.1    Market Overview
                6.2.3.1.1    Solid Organ Transplant
                    6.2.3.1.1.1    Kidney
                    6.2.3.1.1.2    Heart
                    6.2.3.1.1.3    Lungs
                    6.2.3.1.1.4    Liver
                    6.2.3.1.1.5    Intestine
                    6.2.3.1.1.6    Others
                6.2.3.1.2    Stem Cell Transplant
                    6.2.3.1.2.1    Autologous Transplants
                    6.2.3.1.2.2    Allogenic Transplants
                6.2.3.1.3    Tissue Transplant
                    6.2.3.1.3.1    Autografts
                    6.2.3.1.3.2    Allografts
                6.2.3.1.4    Others
        6.2.4    Global Transplantation Market by Application 
            6.2.4.1    Market Overview
                6.2.4.1.1    Clinical Therapeutics
                6.2.4.1.2    Translational Research
                6.2.4.1.3    Diagnostic Purposes
                6.2.4.1.4    Others
        6.2.5    Global Transplantation Market by End-User
            6.2.5.1    Market Overview
                6.2.5.1.1    Hospitals
                6.2.5.1.2    Transplantation Centres
                6.2.5.1.3    Others
        6.2.6    Global Transplantation Market by Region
            6.2.6.1    Market Overview
                6.2.6.1.1    North America 
                    6.2.6.1.1.1    Historical Trend (2016-2022)
                    6.2.6.1.1.2    Forecast Trend (2023-2031)
                6.2.6.1.2    Europe
                    6.2.6.1.2.1    Historical Trend (2016-2022)
                    6.2.6.1.2.2    Forecast Trend (2023-2031)
                6.2.6.1.3    Asia Pacific
                    6.2.6.1.3.1    Historical Trend (2016-2022)
                    6.2.6.1.3.2    Forecast Trend (2023-2031)
                6.2.6.1.4    Latin America
                    6.2.6.1.4.1    Historical Trend (2016-2022)
                    6.2.6.1.4.2    Forecast Trend (2023-2031)
                6.2.6.1.5    Middle East and Africa
                    6.2.6.1.5.1     Historical Trend (2016-2022)
                    6.2.6.1.5.2    Forecast Trend (2023-2031)
7    North America Transplantation Market
    7.1    United States of America
        7.1.1    Historical Trend (2016-2022)
        7.1.2    Forecast Trend (2023-2031)
    7.2    Canada 
        7.2.1    Historical Trend (2016-2022)
        7.2.2    Forecast Trend (2023-2031)
8    Europe Transplantation Market
    8.1    United Kingdom
        8.1.1    Historical Trend (2016-2022)
        8.1.2    Forecast Trend (2023-2031)
    8.2    Germany
        8.2.1    Historical Trend (2016-2022)
        8.2.2    Forecast Trend (2023-2031)
    8.3    France
        8.3.1    Historical Trend (2016-2022)
        8.3.2    Forecast Trend (2023-2031)
    8.4    Italy
        8.4.1    Historical Trend (2016-2022)
        8.4.2    Forecast Trend (2023-2031)
9    Asia Pacific Transplantation Market
    9.1    China
        9.1.1    Historical Trend (2016-2022)
        9.1.2    Forecast Trend (2023-2031)
    9.2    Japan
        9.2.1    Historical Trend (2016-2022)
        9.2.2    Forecast Trend (2023-2031)
    9.3    India
        9.3.1    Historical Trend (2016-2022)
        9.3.2    Forecast Trend (2023-2031)
    9.4    ASEAN
        9.4.1    Historical Trend (2016-2022)
        9.4.2    Forecast Trend (2023-2031)
    9.5    Australia
        9.5.1    Historical Trend (2016-2022)
        9.5.2    Forecast Trend (2023-2031)
10    Latin America Transplantation Market
    10.1    Brazil
        10.1.1    Historical Trend (2016-2022)
        10.1.2    Forecast Trend (2023-2031)
    10.2    Argentina
        10.2.1    Historical Trend (2016-2022)
        10.2.2    Forecast Trend (2023-2031)
    10.3    Mexico
        10.3.1    Historical Trend (2016-2022)
        10.3.2    Forecast Trend (2023-2031)
11    Middle East and Africa Transplantation Market
    11.1    Saudi Arabia
        11.1.1    Historical Trend (2016-2022)
        11.1.2    Forecast Trend (2023-2031)
    11.2    United Arab Emirates
        11.2.1    Historical Trend (2016-2022)
        11.2.2    Forecast Trend (2023-2031)
    11.3    Nigeria
        11.3.1    Historical Trend (2016-2022)
        11.3.2    Forecast Trend (2023-2031)
    11.4    South Africa
        11.4.1    Historical Trend (2016-2022)
        11.4.2    Forecast Trend (2023-2031) 
12    Current Scenario Evaluation and Regulatory Framework
    12.1    Emerging Therapies and Clinical Trials
    12.2    Patent Landscape 
        12.2.1    Patent Overview
            12.2.1.1    Patent Status and Expiry
            12.2.1.2    Timelines from Drug Development to Commercial Launch
            12.2.1.3    New Drug Application
            12.2.1.3.1    Documentation and Approval Process
    12.3    Cost of Treatment
    12.4    Regulatory Framework
        12.4.1    Regulatory Overview
            12.4.1.1    US FDA
            12.4.1.2    EU EMA
            12.4.1.3    INDIA CDSCO
            12.4.1.4    JAPAN PMDA
            12.4.1.5    Others
13    Challenges & Unmet Needs
    13.1    Treatment Pathway Challenges
    13.2    Compliance and Drop-Out Analysis
    13.3    Awareness and Prevention Gaps
14    Global Transplantation Market Dynamics
    14.1    Market Drivers and Constraints
    14.2    SWOT Analysis
    14.3    Porter’s Five Forces Model 
    14.4    Key Demand Indicators 
    14.5    Key Price Indicators 
    14.6    Industry Events, Initiatives & Trends 
    14.7    Value Chain Analysis
15    Supplier Landscape
    15.1    AbbVie Inc.
        15.1.1    Company Overview
        15.1.2    Product Portfolio
        15.1.3    Demographic Reach and Achievements
        15.1.4    Mergers and Acquisitions
        15.1.5    Certifications
    15.2    Arthrex, Inc.
        15.2.1    Company Overview
        15.2.2    Product Portfolio
        15.2.3    Demographic Reach and Achievements
        15.2.4    Mergers and Acquisitions
        15.2.5    Certifications
    15.3    Zimmer Biomet
        15.3.1    Company Overview
        15.3.2    Product Portfolio
        15.3.3    Demographic Reach and Achievements
        15.3.4    Mergers and Acquisitions
        15.3.5    Certifications
    15.4    Medtronic
        15.4.1    Company Overview
        15.4.2    Product Portfolio
        15.4.3    Demographic Reach and Achievements
        15.4.4    Mergers and Acquisitions
        15.4.5    Certifications
    15.5    Novartis AG
        15.5.1    Company Overview
        15.5.2    Product Portfolio
        15.5.3    Demographic Reach and Achievements
        15.5.4    Mergers and Acquisitions
        15.5.5    Certifications
    15.6    Stryker
        15.6.1    Company Overview
        15.6.2    Product Portfolio
        15.6.3    Demographic Reach and Achievements
        15.6.4    Mergers and Acquisitions
        15.6.5    Certifications
    15.7    21st Century Medicine 
        15.7.1    Company Overview
        15.7.2    Product Portfolio
        15.7.3    Demographic Reach and Achievements
        15.7.4    Mergers and Acquisitions
        15.7.5    Certifications
    15.8    BioLife Solutions 
        15.8.1    Company Overview
        15.8.2    Product Portfolio
        15.8.3    Demographic Reach and Achievements
        15.8.4    Mergers and Acquisitions
        15.8.5    Certifications
    15.9    Teva Pharmaceutical Industries Ltd. 
        15.9.1    Company Overview
        15.9.2    Product Portfolio
        15.9.3    Demographic Reach and Achievements
        15.9.4    Mergers and Acquisitions
        15.9.5    Certifications
    15.10    Astellas Pharma Inc. 
        15.10.1    Company Overview
        15.10.2    Product Portfolio
        15.10.3    Demographic Reach and Achievements
        15.10.4    Mergers and Acquisitions
        15.10.5    Certifications
16    Recommendations and Discussion
17    Global Transplantation Distribution Model (Additional Insight)

    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment
18    Payment Methods (Additional Insight)
    18.1    Government Funded
    18.2    Private Insurance
    18.3    Out-of-Pocket

 

*Additional insights provided are customizable as per client requirements.

Key Questions Answered in the Report

The market size is likely to reach a value of USD 13.8 billion in 2022.

The market is likely to grow at a CAGR of 9.4% during the forecast period of 2023-2031 to attain a value of USD 31.5 billion by 2031.

Based on the product, the market is segmented into transplant preservative solutions, transplant diagnostics, tissue products, and immunosuppressive drugs, among others.

Based on the transplant type, the market is categorised into solid organ transplant, tissue transplant, and stem cell transplant.

Based on the application, the market is segmented into clinical therapeutics, translational research, and diagnostic purposes, among others.

Based on the end user, the market is categorised into hospitals and transplantation centres, among others.

The different regions in the market are North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The key companies in the market are AbbVie Inc., Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, 21st Century Medicine, BioLife Solutions, Teva Pharmaceutical Industries Ltd., and Astellas Pharma Inc., among others.

Purchase Full Report

Mini Report

$2499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$6499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$7999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER